Figures and Tables

From the following article:

Exploiting the defensive sugars of HIV-1 for drug and vaccine design

Christopher N. Scanlan, John Offer, Nicole Zitzmann & Raymond A. Dwek

Nature 446, 1038-1045(26 April 2007)

doi:10.1038/nature05818

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

HIV gp160 N-linked glycosylation.

Full size figure and legend (85K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

The carbohydrate shield of gp120.

Full size figure and legend (26K)
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 3

Antigenicity and glycosylation of HIV gp120.

Full size figure and legend (137K)
Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 4

Self/non-self discrimination and antigenic mimicry.

Full size figure and legend (35K)
BACK TO ARTICLE